JP2023085168A - 混注支援システム、混注支援プログラム - Google Patents
混注支援システム、混注支援プログラム Download PDFInfo
- Publication number
- JP2023085168A JP2023085168A JP2022069398A JP2022069398A JP2023085168A JP 2023085168 A JP2023085168 A JP 2023085168A JP 2022069398 A JP2022069398 A JP 2022069398A JP 2022069398 A JP2022069398 A JP 2022069398A JP 2023085168 A JP2023085168 A JP 2023085168A
- Authority
- JP
- Japan
- Prior art keywords
- work
- infusion
- preparation
- information
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 483
- 238000000034 method Methods 0.000 claims abstract description 642
- 230000008569 process Effects 0.000 claims abstract description 364
- 239000003814 drug Substances 0.000 claims abstract description 320
- 229940079593 drug Drugs 0.000 claims abstract description 222
- 238000012545 processing Methods 0.000 claims abstract description 187
- 238000002360 preparation method Methods 0.000 claims description 466
- 239000007924 injection Substances 0.000 claims description 69
- 238000002347 injection Methods 0.000 claims description 69
- 229940090044 injection Drugs 0.000 description 59
- 238000005303 weighing Methods 0.000 description 57
- 238000010586 diagram Methods 0.000 description 52
- 238000003860 storage Methods 0.000 description 43
- 239000000243 solution Substances 0.000 description 28
- 239000007788 liquid Substances 0.000 description 23
- 239000000126 substance Substances 0.000 description 22
- 239000000843 powder Substances 0.000 description 20
- 238000003384 imaging method Methods 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 238000004090 dissolution Methods 0.000 description 14
- 230000008859 change Effects 0.000 description 13
- 238000004088 simulation Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 10
- 230000004044 response Effects 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 239000002246 antineoplastic agent Substances 0.000 description 8
- 229940041181 antineoplastic drug Drugs 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 238000004891 communication Methods 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 2
- 229940000425 combination drug Drugs 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 229940005876 gemcitabine injection Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- -1 infusion Substances 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Images
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021199505 | 2021-12-08 | ||
| JP2021199505 | 2021-12-08 | ||
| JP2022046021 | 2022-03-22 | ||
| JP2022046021 | 2022-03-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023085168A true JP2023085168A (ja) | 2023-06-20 |
| JP2023085168A5 JP2023085168A5 (enExample) | 2025-04-28 |
Family
ID=86775722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022069398A Pending JP2023085168A (ja) | 2021-12-08 | 2022-04-20 | 混注支援システム、混注支援プログラム |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2023085168A (enExample) |
-
2022
- 2022-04-20 JP JP2022069398A patent/JP2023085168A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5696822B1 (ja) | 混注管理装置、混注装置、混注管理プログラム | |
| JP2016529024A (ja) | 薬剤の手作業の調合を監視するため、記録に残すため、及び支援するための方法及び装置 | |
| CN107427413B (zh) | 配药管理装置、混注装置 | |
| JP2024091797A (ja) | 混注管理システム、混注管理プログラム、及び混注管理方法 | |
| JP7255734B2 (ja) | 混注支援システム | |
| JP2013125377A (ja) | 処方データベース、処方データベースを用いた処方監査システム、及び、処方監査システムに用いられる処方データベースの更新方法 | |
| JP2023085168A (ja) | 混注支援システム、混注支援プログラム | |
| JP5939371B1 (ja) | 混注装置、混注制御プログラム | |
| JP5828832B2 (ja) | 調剤支援システム | |
| JP2001331583A (ja) | 薬剤検索システム | |
| JP7140957B2 (ja) | 医療情報管理システム及び医療情報管理プログラム | |
| JP2018185636A (ja) | 有害事象管理システム、有害事象管理プログラム | |
| JP7594181B2 (ja) | 調製支援システム及び調製支援プログラム | |
| JP4055483B2 (ja) | 薬品設置システム | |
| WO2025005163A1 (ja) | 調製管理システム及び調製管理プログラム | |
| JP2015047362A (ja) | 薬剤データ入力装置およびプログラム | |
| JP2019180586A (ja) | 医療支援システムおよび作業台 | |
| JP2018165867A (ja) | 投薬管理システム、投薬管理プログラム | |
| JP2023159607A (ja) | 医療情報管理システム及び医療情報管理プログラム | |
| JP2019118701A (ja) | 調整支援システム | |
| Nguyen | Handbook on Injectable Drugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250418 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250418 |